DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
0.73%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
74.4%
Neutral
25.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $41 |
27%
upside
| 2 | -1.7% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $48 |
109%
upside
| 1 | +6.9% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $75 |
25%
upside
| 3 | +7% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $432 |
22%
upside
| 5 | +6.3% |
0
%
| 18 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $299 |
43%
upside
| 3 | +4% |
0
%
| 18 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $177 |
0%
downside
| 4 | – |
–
| 9 Feb ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $12 |
18%
downside
| 1 | – |
–
| 28 Jan ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $223 |
18%
upside
| 1 | -8.7% |
0
%
| 16 Jan ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $18 |
165%
upside
| 1 | +2.9% |
0
%
| 9 Jan ‘26 3 months ago |
|
|
|
Overweight
Reiterated
| $219 |
8%
upside
| 2 | +29% |
0
%
| 10 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $9 |
341%
upside
| 1 | -16% |
0
%
| 25 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $8 |
85%
upside
| 1 | -31% |
0
%
| 7 Nov ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $8 |
26%
upside
| 1 | – |
–
| 7 Nov ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| $41 |
25%
upside
| 1 | +5.9% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| $13 |
7%
downside
| 1 | +20% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $179 |
34%
upside
| 3 | +7% |
0
%
| 29 Oct ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| $45 |
30%
upside
| 1 | -10% |
0
%
| 23 Oct ‘25 5 months ago |
|
|
|
Overweight
Upgraded
| $65 |
26%
upside
| 2 | +4.9% |
0
%
| 9 Oct ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $25 |
9%
upside
| 2 | – |
–
| 8 Aug ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $121 |
162%
upside
| 2 | -36% |
0
%
| 1 Aug ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $8.50 |
2%
downside
| 1 | +67% |
–
| 17 Jun ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $18 |
84%
upside
| 1 | -22% |
0
%
| 15 May ‘25 11 months ago |
|
|
|
Neutral
Reiterated
| $37 |
8%
upside
| 1 | – |
–
| 9 May ‘25 11 months ago |
|